» Authors » Yingjia Guo

Yingjia Guo

Explore the profile of Yingjia Guo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Y, Zhou J, Li X, Xiao Y, Zhang J, Yang Y, et al.
Front Aging Neurosci . 2021 Mar; 13:648115. PMID: 33716719
Elderly patients suffer more brain damage in comparison with young patients from the same ischemic stroke. The present study was undertaken to test the hypothesis that suppressed hypoxia-inducible factor-1 (HIF-1)...
2.
Zhou Y, Shan J, Guo Y, Li S, Long D, Li Y, et al.
J Immunol Res . 2016 Aug; 2016:5730674. PMID: 27547767
Objective. To dissect the efficacy of Tol-DC therapy with or without IS in multiple animal models of transplantation. Methods and Results. PubMed, Medline, Embase, and the Cochrane Library were searched...
3.
Guo Y, Feng L, Zhou Y, Sheng J, Long D, Li S, et al.
Transplant Rev (Orlando) . 2015 May; 29(3):127-34. PMID: 26007634
Ischemia-reperfusion injury (IRI) induces inevitable complications in liver transplantation. Many studies have demonstrated that hypoxia-inducible factor 1α (HIF-1α) plays an important role in IRI. However, the mechanism of its pleiotropic...
4.
Li X, Han P, Guo Y, Sun H, Xiao Y, Kang Y
J Neurosci Methods . 2015 Apr; 249:59-65. PMID: 25864803
Background: Currently-used cerebellomedullary cistern puncture method for collecting cerebrospinal fluid (CSF) from monkeys is simple, inexpensive, and practical, but with high risk for brainstem injury and CSF blood contamination. An...
5.
Sun G, Zhou Y, Li H, Guo Y, Shan J, Xia M, et al.
J Biomed Sci . 2013 Dec; 20:100. PMID: 24364919
Background: Hypoxia-inducible factor-1 alpha (HIF-1α) is one of the key regulators of hypoxia/ischemia. MicroRNA-494 (miR-494) had cardioprotective effects against ischemia/reperfusion (I/R)-induced injury, but its functional relationship with HIF-1α was unknown....
6.
Sun G, Shan J, Li Y, Feng L, Zhou Y, Guo Y, et al.
J Evid Based Med . 2013 Dec; 6(3):185-96. PMID: 24325375
Background: Postoperative infections and rejection are the main limiting factors of small intestine allograft survival. In this study, we performed a systematic review and meta-analysis to review rat small intestine...
7.
Zhou Y, Shan J, Li Y, Guo Y, Sun G, Yang T, et al.
J Evid Based Med . 2013 Jul; 6(2):90-103. PMID: 23829801
Objective: We aim to systematically review adoptive transfusion of tolerogenic dendritic cells (Tol-DCs) induced by different ways to affect skin allograft survival in mice. Methods: We searched PubMed and EMbase...
8.
Lu J, Luo L, Guo Y, Long D, Wei L, Shan J, et al.
J Evid Based Med . 2013 May; 4(2):106-21. PMID: 23672701
Background And Objective: Human major histocompatibility complex class I-related gene A (MICA) is reportedly associated with poor transplant outcomes and a high risk of acute and chronic rejection in solid...
9.
Wu W, Shan J, Li Y, Luo L, Sun G, Zhou Y, et al.
J Evid Based Med . 2013 May; 5(3):139-53. PMID: 23672221
Background And Objective: Tolerogenic DCs (Tol-DCs), a group of cells with imDC phenotype, can stably induce T cells low-reactivity and immune tolerance. We systematically reviewed the adoptive transfusion of Tol-DCs...
10.
Sun G, Shan J, Li Y, Zhou Y, Guo Y, Wu W, et al.
PLoS One . 2012 Dec; 7(12):e52096. PMID: 23272217
Objective: The first Phase I study of autologous tolerogenic dendritic cells (Tol-DCs) in Type 1 diabetes (T1D) patients was recently completed. Pancreatic islet transplantation is an effective therapy for T1D,...